Table 2.
ERP P450 Amplitude Indices (citicoline-caffeine group vs. placebo control).
| P450 Amplitudes | Citicoline Supplement (n = 30) |
Placebo (n = 30) |
|---|---|---|
| Mean (SD) | Mean (SD) | |
| Fp1* | 1.515 (4.807) | .006 (5.055) |
| Fp2 | 1.670 (5.065) | 1.484 (5.613) |
| F7* | 4.429 (3.262) | 2.505 (3.851) |
| F3** | 7.071 (4.124) | 3.915 (4.790) |
| Fz** | 7.477 (4.648) | 4.132 (5.164) |
| F4** | 7.160 (4.026) | 3.917 (4.940) |
| F8 | 3.909 (3.612) | 3.044 (3.720) |
| FC3** | 8.774 (3.683) | 5.202 (5.031) |
| FCz** | 9.489 (4.637) | 5.633 (5.583) |
| FC4** | 8.917 (4.052) | 4.956 (4.806) |
| T3** | 6.117 (2.680) | 3.268 (2.943) |
| C3** | 10.020 (3.698) | 6.510 (4.775) |
| Cz** | 11.185 (4.457) | 7.327 (5.560) |
| C4** | 9.921 (3.798) | 6.317 (5.265) |
| T4* | 6.224 (2.714) | 4.175 (3.963) |
| CP3* | 10.545 (3.892) | 7.556 (4.411) |
| CPz** | 12.131 (4.051) | 8.744 (5.109) |
| CP4* | 10.623 (3.986) | 7.668 (4.897) |
| T5 | 6.718 (2.816) | 5.810 (3.373) |
| P3 | 10.051 (4.271) | 8.112 (4.313) |
| Pz* | 12.634 (4.087) | 9.618 (4.828) |
| P4* | 10.498 (4.534) | 7.982 (4.176) |
| T6 | 6.093 (3.546) | 5.686 (3.438) |
| O1 | 7.901 (3.700) | 7.401 (4.113) |
| Oz | 8.603 (3.467) | 7.648 (4.770) |
| O2 | 8.137 (3.530) | 7.655 (4.564) |
*
p < .05,
**
p < .01